[Value of premedication with gonadotropin releasing hormone agonists before transcervical resection of solitary submucous myoma].
In a retrospective study, the value of pretreatment with a gonadotropin-releasing-hormone (GnRH) agonist before hysteroscopic myoma resection was assessed in 31 patients suffering from menorrhagia. No difference in operating time, intra-operative fluid deficit, blood loss and postoperative eumenorrhoea rate was found between pretreated and non-pretreated patients with solitary submucous myomas smaller than 4 cm in diameter. Thus, pretreatment with GnRH agonists before the resection of small solitary submucous myomas has no benefit for the patients.